Tue, Mar 3, 2015, 7:08 AM EST - U.S. Markets open in 2 hrs 22 mins


% | $
Quotes you view appear here for quick access.

Celgene Corp. (CELG) Message Board

  • rob_cos rob_cos Dec 4, 2012 10:05 AM Flag

    10 very near term catalysts that will bust us through 80 and bring us to all time highs by January end imo..

    10 very near term catalysts that will bust us through 80 and bring us to all time highs by January end imo....

    Even I have been trading some calls in what feels like a continuous loop from low 78s to high 79s but with ASH starting friday, psoriasis and PsA Ph 3 data coming this month and pomalidomide approval coming soon - well its time to stop selling the mid to high 79s now.

    1) Apremilast Psoriasis top-line data this month
    2) Apremilast PsA Palace 4 if first all Monotherapy/dmard trial is similar to biologics (important as the first three Ph 3 PsA trials showed amazing safety profile and biologic like ACR 20 scores in a this SUBSET but this is first Ph 3 where entire trial is Monotherapy.

    3) ASH – Pom Ph 3 MM-003 late breaker, NHL, MM-015 update – 250 presentations and posters

    4) Pomalidomide approval – coming early

    5) China Approval of Revlimid in relapsed/refractory MM

    6) Other international approvals or pricing okays in various countries – Brazil, Mexico, Russia, So Korea etc

    7) JP Morgan conference – will be positive imo both 2013 guidance and forward

    8) Stem Cell Crohns data – where oh where is the Stem Cell data?

    9) DETAIL of the amazing Ph 3 Pancreatic Cancer trial in January in San Francisco at the ASCO GI meeting

    10) MM-020 – the largest front line myeloma trial in history Rev-Dex versus Thal-melphalan-P which should have interim look – interesting will be if thalMP arm has more SPMs than Rev-Dex. If this data is really good on the first interim look we could sprint to $100+ as front line EU approval post CHMP debacle is the only reason we are not in the 90s right now imo and the reason we have not been fully paid for the amazing Abraxane and Apremilast news

    SortNewest  |  Oldest  |  Most Replied Expand all replies
120.31-1.22(-1.00%)Mar 2 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
JD.com, Inc.
NASDAQMon, Mar 2, 2015 4:00 PM EST
NXP Semiconductors NV
NASDAQMon, Mar 2, 2015 4:00 PM EST